ESC Premium Access

Panel of emerging cardiac biomarkers in patients with acute chest pain

Congress Presentation

About the speaker

Mr Julian Hupf

University Hospital Regensburg, Regensburg (Germany)
0 follower

9 more presentations in this session

Fibroblast growth factor-23 (FGF23), an early biomarker of sublinical kidney dysfunction, is associated with poor prognosis in acute coronary syndrome patients

Speaker: Doctor T. Yndigegn (Lund, SE)

Thumbnail

Physical exercise induces coronary artery collateral growth and affects cardiovascular biomarkers: A biomarker sub-analysis of the EXCITE trial

Speaker: Associate Professor M. Lichtenauer (Salzburg, AT)

Thumbnail

Direct comparison of the 0/1h- and 0/3h-algorithm for early rule-out of acute myocardial infarction

Speaker: Associate Professor P. Badertscher (Basel, CH)

Thumbnail

The association of biological markers of inflammation with the severity of cardiofibrosis in patients with ST-segment elevation myocardial infarction

Speaker: Professor O. Barbarash (Kemerovo, RU)

Thumbnail

Validation of limb leads in localizing culprit artery in inferior STEMI

Speaker: Doctor A. Smith (Biloxi, US)

Thumbnail

Access the full session

Poster Session 2 - Biomarkers in acute coronary syndromes

Speakers: Mr J. Hupf, Doctor T. Yndigegn, Associate Professor M. Lichtenauer, Associate Professor P. Badertscher, Professor O. Barbarash...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb